Trials / Completed
CompletedNCT03183102
The Role of the Gut Microbiota in Estrogen Metabolism and Dietary Flax as a Potential Modulator.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Colorado State University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this pilot study is to determine if suppressing estrogen in premenopausal women results in changes in gut microbiota and if dietary flaxseed modulates these changes.
Detailed description
This pilot study will begin to address whether gut microbiota change with estrogen suppression. Specifically, the investigators will test whether gut microbial diversity and abundance change in response to estrogen suppression and consumption of dietary flaxseed. To test this possibility the investigators will recruit premenopausal women (age 20-40 years old)and collect fecal samples before and after 1 month of estrogen suppression with GnRH agonist. The investigators will analyze the gut microbiota in response to estrogen loss and whether this differs with the consumption of flaxseed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Flaxseed | 2 months of dietary flaxseed supplementation |
Timeline
- Start date
- 2017-10-01
- Primary completion
- 2022-12-30
- Completion
- 2022-12-30
- First posted
- 2017-06-09
- Last updated
- 2024-07-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03183102. Inclusion in this directory is not an endorsement.